Tech Company M&A Transactions

Solstice Neurosciences Acquisition

Solstice Neurosciences was bought by US WorldMeds. The transaction was announced on 8/13/2010. Deal value was $35.7 million.

Transaction Overview

Acquired By
Announced On
8/13/2010
Transaction Type
M&A
Amount
$35,700,000
M&A Terms
Additional terms of the transaction were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
701 Gateway Boulevard 250
South San Francisco, CA 94080
USA
Email Address
Overview
Solstice Neurosciences, Inc. is a biopharmaceuticalcompany focused on the development, manufacturing, sales and marketing ofspecialty products.
Profile
Solstice Neurosciences LinkedIn Company Profile
Social Media
Solstice Neurosciences Company Twitter Account
Company News
Solstice Neurosciences News
Facebook
Solstice Neurosciences on Facebook
YouTube
Solstice Neurosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dennis Smith
  Dennis Smith LinkedIn Profile  Dennis Smith Twitter Account  Dennis Smith News  Dennis Smith on Facebook
Chief Financial Officer
Michael Pagnotta
  Michael Pagnotta LinkedIn Profile  Michael Pagnotta Twitter Account  Michael Pagnotta News  Michael Pagnotta on Facebook
VP - Operations
Patrick Murphy
  Patrick Murphy LinkedIn Profile  Patrick Murphy Twitter Account  Patrick Murphy News  Patrick Murphy on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/12/2010: Embedly venture capital transaction
Next: 8/13/2010: WePay venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on funding rounds that are announced publicly. All VC database entries reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary